No Data
No Data
No Data
No Data
No Data
PURE Bioscience GAAP EPS of -$0.01, Revenue of $0.33M
Seeking AlphaMar 18 16:52 ET
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
Update on Business and PURE's SDC-Based Antimicrobial Food Safety SolutionsEL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patent
BusinesswireMar 18 16:05 ET
PURE Bioscience GAAP EPS of -$0.01, Revenue of $0.72M
Seeking AlphaDec 14, 2023 17:02 ET
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results
Update on Business and PURE's SDC-Based Antimicrobial Food Safety SolutionsEL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patent
BusinesswireDec 14, 2023 16:02 ET
PURE Bioscience GAAP EPS of -$0.04, Revenue of $1.87M
Seeking AlphaOct 30, 2023 17:32 ET
PURE Bioscience Reports Fiscal 2023 Financial Results
Update on Business and PURE's SDC-Based Antimicrobial Food Safety SolutionsEL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patent
BusinesswireOct 30, 2023 16:05 ET
No Data
No Data